CINECA IRIS Institutional Research Information System

TALIANI, SABRINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.144
AS - Asia 8.474
EU - Europa 8.179
SA - Sud America 1.168
AF - Africa 425
OC - Oceania 67
Continente sconosciuto - Info sul continente non disponibili 2
Totale 35.459
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.561
IT - Italia 3.404
SG - Singapore 2.721
CN - Cina 2.545
HK - Hong Kong 1.342
SE - Svezia 1.232
BR - Brasile 986
DE - Germania 880
BG - Bulgaria 550
CA - Canada 461
VN - Vietnam 450
TR - Turchia 420
GB - Regno Unito 415
AT - Austria 316
FI - Finlandia 307
RU - Federazione Russa 305
IN - India 218
UA - Ucraina 204
KR - Corea 188
FR - Francia 174
JP - Giappone 154
CI - Costa d'Avorio 103
NG - Nigeria 85
BD - Bangladesh 72
MX - Messico 66
NL - Olanda 64
AU - Australia 63
CH - Svizzera 63
SN - Senegal 62
IQ - Iraq 61
AR - Argentina 58
BE - Belgio 56
PL - Polonia 54
ZA - Sudafrica 51
PK - Pakistan 41
ES - Italia 35
UZ - Uzbekistan 33
SA - Arabia Saudita 32
ID - Indonesia 31
EG - Egitto 29
VE - Venezuela 27
EC - Ecuador 26
KE - Kenya 24
CO - Colombia 22
CZ - Repubblica Ceca 20
JO - Giordania 19
MA - Marocco 17
AZ - Azerbaigian 16
IE - Irlanda 16
LT - Lituania 15
MY - Malesia 14
PY - Paraguay 14
DZ - Algeria 13
OM - Oman 13
AE - Emirati Arabi Uniti 12
PE - Perù 12
TW - Taiwan 12
IR - Iran 11
JM - Giamaica 11
TT - Trinidad e Tobago 11
KZ - Kazakistan 10
AL - Albania 9
CL - Cile 9
PT - Portogallo 9
GR - Grecia 8
LB - Libano 8
BJ - Benin 7
ET - Etiopia 7
IL - Israele 7
DK - Danimarca 6
PA - Panama 6
PS - Palestinian Territory 6
UY - Uruguay 6
BF - Burkina Faso 5
BH - Bahrain 5
BO - Bolivia 5
DO - Repubblica Dominicana 5
EE - Estonia 5
GE - Georgia 5
HU - Ungheria 5
RO - Romania 5
BN - Brunei Darussalam 4
CR - Costa Rica 4
NZ - Nuova Zelanda 4
PH - Filippine 4
PR - Porto Rico 4
QA - Qatar 4
TN - Tunisia 4
BA - Bosnia-Erzegovina 3
BB - Barbados 3
HR - Croazia 3
KG - Kirghizistan 3
NI - Nicaragua 3
SO - Somalia 3
ZM - Zambia 3
CG - Congo 2
CY - Cipro 2
GA - Gabon 2
GD - Grenada 2
GY - Guiana 2
Totale 35.414
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.761
Ashburn 1.655
Ann Arbor 1.492
Singapore 1.469
Hong Kong 1.324
Houston 1.319
Serra 1.185
Fairfield 1.039
Chandler 1.030
Santa Clara 929
Dallas 850
Milan 639
Sofia 550
Shanghai 529
San Jose 522
Beijing 511
Seattle 424
New York 423
Wilmington 397
Ottawa 376
Cambridge 326
Los Angeles 297
Boardman 292
Izmir 281
Vienna 265
Princeton 264
Hefei 251
Jacksonville 249
Lawrence 220
Nanjing 177
Seoul 177
Medford 175
Frankfurt am Main 173
London 166
Des Moines 152
Dong Ket 147
Rho 129
Pisa 124
Istanbul 104
Abidjan 103
Redondo Beach 103
Dearborn 102
Rome 99
Munich 90
Buffalo 84
Lagos 83
Tokyo 79
Council Bluffs 77
São Paulo 77
Bremen 75
Helsinki 71
Florence 69
Ho Chi Minh City 69
Chicago 64
Dakar 62
Nanchang 60
Turku 60
San Diego 56
Brussels 55
Bern 54
The Dalles 50
Redwood City 49
Boulder 48
Ogden 48
Kunming 45
Warsaw 44
Düsseldorf 43
Jüchen 41
Sydney 41
Columbus 40
Pune 40
Changsha 38
Fuzhou 38
Lucca 38
Shenyang 38
Hanoi 36
Hebei 35
San Francisco 34
Belo Horizonte 31
Livorno 31
Tashkent 31
Tianjin 31
Toronto 30
Johannesburg 29
Paris 29
Guangzhou 27
Nürnberg 27
Nuremberg 26
Quanzhou 26
Rio de Janeiro 26
Hangzhou 24
Pistoia 24
Alessandria 23
Dhaka 23
Norwalk 23
Brasília 22
Falls Church 22
Montreal 22
Phoenix 22
Stockholm 22
Totale 25.302
Salva come PNG Salva come JPEG
Nome #
1,2-Benzisothiazole Derivatives Bearing 4-, 5-, or 6-Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions 387
TSPO ligand residence time influences human glioblastoma multiforme cell death/life balance 323
N, N-Dialkyl-2-phenylindol-3-ylglyoxylamides.A new class of potent and selective ligands at the Peripheral benzodiazepine receptor 275
Benzofuroxane Derivatives as Multi Effective Agents for the Treatment of Cardiovascular Diabetic Complications. Synthesis, Functional Evaluation, and Molecular Modeling Studies 266
Apoptosis Therapy in Cancer: The First Single-molecule Co-activating p53 and the Translocator Protein in Glioblastoma 261
Exploiting the Pyrazolo[3,4-d]pyrimidin-4-one ring system as a useful template to obtain potent adenosine deaminase inhibitors, 260
Iminothioethers as Hydrogen Sulfide Donors: From the Gasotransmitter Release to the Vascular Effects 253
Bax Activation Blocks Self-Renewal and Induces Apoptosis of Human Glioblastoma Stem Cells 235
[1,2,4]Triazino[4,3-a]benzimidazole Acetic Acid Derivatives: a New Class of Selective Aldose Reductase Inhibitors 225
Two mixed valence diruthenium(ii,iii) isomeric complexes show different anticancer properties 225
Allosteric modulators of human A2B adenosine receptor. 223
Deepening the Topology of the Translocator Protein Binding Site by Novel N,N-Dialkyl-2-arylindol-3-ylglyoxylamides 223
The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities 219
G-Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitors: Current Trends and Future Perspectives. 216
TSPO-ligands prevent oxidative damage and inflammatory response in C6 glioma cells by neurosteroid synthesis 215
TSPO PIGA ligands promote neurosteroidogenesis and human astrocyte well-being 212
[1,2,4]Triazino[4,3-a]benzimidazole Acetic Acid Derivatives: A New Class of Selective Aldose Reductase Inhibitors 211
3-aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-ones: Tricyclic heteroaromatic derivatives as a new class of benzodiazepine receptor ligands 207
p53 Functional Inhibitors Behaving Like Pifithrin-β Counteract the Alzheimer Peptide Non-β-amyloid Component Effects in Human SH-SY5Y Cells. 207
Sulfonamides incorporating heteropolycyclic scaffolds show potent inhibitory action against carbonic anhydrase isoforms I, II, IX and XII 205
An update into the medicinal chemistry of translocator protein (TSPO) ligands 203
3-Aryl[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-ones: A New Class of Selective A1 Adenosine Receptor Antagonists 201
TSPO ligand residence time: a new parameter to predict compound neurosteroidogenic efficacy 200
Structure-Based Lead Optimization and Biological Evaluation of BAX Direct Activators as Novel Potential Anticancer Agents. 198
Identification of Anxiolytic/Nonsedative Agents among Indol-3-ylglyoxylamides Acting as Functionally Selective Agonists at the γ-Aminobutyric Acid-A (GABAA) α2 Benzodiazepine Receptor 198
Long lasting inhibition of Mdm2-p53 interaction potentiates mesenchymal stem cell differentiation into osteoblasts 197
Geometrically Constrained Analogues N-Benzylindolylglyoxylylamides: [1,2,4]Triazino[4,3-a]benzimidazol-4(10H)-one Derivatives as Potential New Ligands at the Benzodiazepine Receptor. 196
Long Residence Time at the Neurosteroidogenic 18 kDa Translocator Protein Characterizes the Anxiolytic Ligand XBD173 196
Arylthioamides as H2S Donors:l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo 194
Structure-Based Optimization of Tyrosine Kinase Inhibitor CLM3. Design, Synthesis, Functional Evaluation, and Molecular Modeling Studies. 191
Medicinal chemistry of indolylglyoxylamide TSPO high affinity ligands with anxiolytic-like effects 190
Allosteric Modulators for Adenosine Receptors: An Alternative to the Orthosteric Ligands 188
Drug-target Residence Time: a key parameter in glial responses to TSPO ligands 188
5-Amino-2-phenyl[1,2,3]triazolo[1,2-a][1,2,4]benzotriazin-1-one: a Versatile Scaffold to Obtain Potent and Selective A3 Adenosine Receptor Antagonists 187
2-(Benzimidazol-2-yl)quinoxalines: A Novel Class of selective Antagonists at Human A1 and A3 Adenosine Receptors Designed by 3D Database Searching 186
Residence Time (RT), a new parameter to predict neurosteroidogenic efficacy of Translocator Protein (TSPO) ligands: N,N-dialkyl-2-arylindol-3-ylglyoxylamides, a case study 186
Pyrido[1,2-a]pyrimidin-4-one derivatives as a novel class of selective aldose reductase inhibitors exhibiting antioxidant activity 185
Benzothiopyranoindole-Based Antiproliferative Agents: Synthesis, Cytotoxicity, Nucleic Acids Interaction, and Topoisomerases Inhibition Properties. 185
Investigation of new 2-aryl substituted Benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors targeting vascular endothelial growth factor receptor 2 185
Studies in search for selective ligands for GABAA/BzR receptor subtypes: synthesis and biological evaluation of 4'-modified N-(benzyl)indol-3-ylglyoxylamides 184
Refinement of Structure-activity Relationships of the Triazinobenzimidazole A1AR Antagonists 184
Phenylpyrazolo[1,5-a]quinazolin-5(4H)-one: a suitable scaffold for the development of non-camptothecin Topoisomerase I (Top1) inhibitors 184
Osteoblast differentiation and survival: A role for A2B adenosine receptor allosteric modulators. 184
Structural requirements to obtain highly potent and selective 18 kDa Translocator Protein (TSPO) ligands 183
Benzo[d]isothiazoles and Matrix Metalloproteinases. Searching for Novel and Selective Inhibitors of MMP9 182
Synthesis of a Novel Purine-Containing Heterocyclic Ring System: 8,10-Dimethylindolo[2',3':5,6][1,2,4]triazino[4,3-f]purine-9,11(8H,10H,13H)dione 182
"2-Phenyl[1,2,3]triazole[1,2-a][1,2,4]triazin-1,5(6H)-dione: a derivative of a new tricyclic heteroaromatic system with high affinity at the benzodiazepine receptor" 181
3-(Fur-2-yl)-10-(2-Phenylethyl)-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one, a Novel Adenosine Receptor Antagonist with (2A)-Mediated Neuroprotective EffeCTS 180
Medicinal chemistry of indolylglyoxylamide GABAA/BzR high affinity ligands: identification of novel anxiolytic/non sedative agents 180
3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: a novel template for the design of highly selective A(2B) adenosine receptor antagonists 178
Metformin conjugates and therapeutic use thereof 177
Novel Pyrazolo[3,4-d]pyrimidine Derivatives as ATP-competitive Inhibitors of the Epidermal Growth Factor Receptor Protein Tyrosine Kinase 176
“Synthesis and antiproliferative evaluation of new substituted Benzothiopyrano[4,3-c] condensed ring systems” 176
Novel N(2)-Substituted Pyrazolo[3,4-d]pyrimidine Adenosine A(3) Receptor Antagonists: Inhibition of A(3)-Mediated Human Glioblastoma Cell Proliferation (dagger) 175
3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: A Novel Template for the Design of Highly Selective A(2B) Adenosine Receptor Antagonists. 175
Recent Advances in the Development of Dual Topoisomerase I and II Inhibitors as Anticancer Drugs 175
Targeting the 18-kDa translocator protein: Recent perspectives for neuroprotection 174
Modulation of A2B Adenosine Receptor by 1-Benzyl-3-ketoindole Derivatives 173
Novel Potent and Selective Human Adenosine A3 Receptor Antagonists Containing the Pyrazolo[3,4-d]pyrimidine Ring System. Synthesis and Biological Evaluation 171
11C-ER176, a radioligand for 18-kDa translocator protein, has adequate sensitivity to robustly image all three affinity genotypes in human brain 170
The Anxiolytic Etifoxine Binds to TSPO Ro5-4864 Binding Site with Long Residence Time Showing a High Neurosteroidogenic Activity 170
Modulation of A2B adenosine receptor by 1-benzyl-3-ketoindole derivatives 170
A mixed-valence diruthenium(ii,iii) complex endowed with high stability: from experimental evidence to theoretical interpretation 169
Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: Synthesis and biological evaluation. 167
Translocator protein (tspo) ligand residence time: a new parameter to predict neurosteroidogenic efficacy for n,n-dialkyl-2-arylindol-3-ylglyoxylamides (PIGAs) 166
Synthesis of Pyrimido[1,2-a]benzimidazol-4(10H)-one Derivatives and Evaluation of their Interactions with DNA 165
Characterization of a new fluorescent irreversible ligand to translocator protein (18 kDa) 165
Discovery of Pyrido[3′,2′:5,6]thiopyrano[4,3- d]pyrimidine-Based Antiproliferative Multikinase Inhibitors 164
Antitumoral effect by induction of collapse of mitochondrial membrane potential in Glioblastoma Multiforme cells 163
Anxiolytic properties of a 2-phenylindolglyoxylamide TSPO ligand: Stimulation of in vitro neurosteroid production affecting GABA(A) receptor activity 163
Synthesis and Biological Evaluation of 4-Phenylquinazoline-2-carboxamides Designed as a Novel Class of Potent Ligands of the Translocator Protein 162
4-Substituted Benzenesulfonamides Incorporating Bi/Tricyclic Moieties Act as Potent and Isoform-Selective Carbonic Anhydrase II/IX Inhibitors 162
H2S-RELEASING PROPERTIES OF NEW THIOAMIDE, IMINOTHIOETHER AND ISOTHIOCYANATE DERIVATIVES 161
A1 adenosine receptor antagonists, 3-aryl[1,2,4]triazino[4,3-a]benzimidazol-4-(10H)-ones (ATBIs) and N-alkyl and N-acyl-(7-substituted-2-phenylimidazo[1,2-a][1,3,5]triazin-4-yl)amines (ITAs): different recognition of bovine and human binding sites 161
A cyanine-based NIR fluorescent Vemurafenib analog to probe BRAFV600E in cancer cells 159
A complex bearing TSPO PIGA ligand coordinated to the [Au(PEt3)]+ pharmacophore is highly cytotoxic against ovarian cancer cells 159
New fluorescent probes for the pheripheral-type benzodiazepine receptor: synthesis and biological application 159
Novel N-substituted indol-3-ylglyoxylamides probing the LDi and L1L2 lipophilic regions of the benzodiazepine receptor site in search for subtype-selective ligands 159
An irreversible ligand of the 18 kDa Translocator Protein induces rapidly ΔΨm collapse and activates apoptosis in human glioblastoma multiforme cells. 158
Acetic acid aldose reductase inhibitors bearing a five-membered heterocyclic core with potent topical activity in a visual impairment rat model 157
Translocator protein ligands as promising therapeutic tools for anxiety disorders 157
Benzothiopyranoindole- and pyridothiopyranoindole-based antiproliferative agents targeting topoisomerases 157
Tertiary amides with a five-membered heteroaromatic ring as new probes for the translocator protein 156
Exploiting the 4-Phenylquinazoline Scaffold for the Development of High Affinity Fluorescent Probes for the Translocator Protein (TSPO) 156
Derivatives of 4-Amino-6-hydroxy-2-mercaptopyrimidine as Novel, Potent, and Selective A3 Adenosine Receptor Antagonists 156
The human microglial surveillant phenotype is preserved by de novo neurosteroidogenesis through the control of cholesterol homeostasis: Crucial role of 18 kDa Translocator Protein 155
Nuovi derivati acidi acetici quali potenti inibitori dell’Aldoso Reduttasi 155
Synthesis and Biological Evaluation of Pyrido[1,2-d]pyrimidin-4-one Derivatives as Novel Aldose Reductase Inhibitors Exhibiting Antioxidant Activity 155
Novel fluorescent triazinobenzimidazole derivatives as probes for labelling human A1 and A2B adenosine receptor subtypes 155
Pyrazolo[3,4,-d]pyrimidine-4-one Derivatives as Novel and Potent Inhibitors of Adenosine Deaminase 153
Highlighting the new advances in drug discovery and development 153
Geometrically Constrained Derivatives of Indolylglyoxylamides as Ligands Binding the GABAA/BzR Complex. 153
Long lasting MDM2/Translocator protein modulator: a new strategy for irreversible apoptosis of human glioblastoma cells 153
Carbonic anhydrase activation profile of indole-based derivatives 153
Synthesis of New Heterocyclic Ring Systems via [1,3,5]Triazino[1,2-a]benzimidazole Derivatives 152
Small Molecules Containing the Benzo[d]isotiazole Ring System as Novel ATP-Competitive Inhibitors of Epidermal Growth Factor Receptor protein Tyrosine Kinase 151
Naphtho[1,2-d]isothiazole Acetic Acid Derivatives as a Novel Class of Selective Aldose Reductase Inhibitors 151
N,N-Dialkyl-2-phenylindol-3- ylglyoxylamides. A New Class of Potent and Selective Ligands at the Peripheral Benzodiazepine Receptor 151
Microwave-assisted Suzuki Coupling in Aqueous Media: a Useful Tool for the Synthesis of 3-Arylindazole Derivatives 150
Modulation of PAR(1) signaling by benzimidazole compounds 150
Totale 18.577
Salva come PNG Salva come JPEG
Categoria #
all - tutte 97.894
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.894
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.044 0 0 0 0 0 0 62 162 231 137 115 337
2021/20222.662 79 229 119 142 421 377 100 116 95 72 147 765
2022/20233.787 449 581 274 373 421 483 39 276 643 22 177 49
2023/20242.829 310 282 306 190 406 505 174 72 39 68 165 312
2024/20258.252 60 286 103 526 853 829 575 375 758 1.063 880 1.944
2025/20265.873 476 1.139 1.087 777 989 797 608 0 0 0 0 0
Totale 36.100